Open AccessP030 Chemokines and Adipokines As Biomarkers of Crohn’s Disease Activity: A Systematic Review Of The Literature
Author(s) -
Mello Juliana,
Gomes Luis,
Julian Silva,
Siqueira Natália,
Pascoal Lívia,
Martinez A. Carlos,
Ayrizono Maria de Lourdes,
Leal Raquel
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000798720.38064.92
Subject(s) - medicine , adipokine , disease , cochrane library , crohn's disease , chemokine , inflammatory bowel disease , systematic review , inclusion and exclusion criteria , immunology , medline , meta analysis , inflammation , pathology , leptin , alternative medicine , political science , law , obesity
Crohn's disease (CD) is an inflammatory bowel disease (IBD) that can affect the entire gastrointestinal tract and can have a major impact on the patient's quality of life. Asymptomatic patients, or those with mild symptoms, experience the active disease with subclinical manifestation. A systematic review (SR) was performed to look for evidence for the role of chemokines and adipokines as markers for CD activity.